Osakidetza Begins Child Immunisation Against the Sincitial Respiratory Virus
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.7 Articles
7 Articles
The Xunta, through the Directorate Xeral de Saúde Pública de la Consellería de Sanidade, launched a new vaccination campaign against the respiratory syncytial virus (VRS) on Monday with the aim of preventing hospitalizations for this virus in infants. In a statement, the Consellería de Sanidade recalled that this protection was introduced in Galicia in a pioneering way in 2023 and allows the reduction of hospitalizations by more than 90% for thi…
Deia
To protect children, Osakidetza has begun the annual campaign to immunize children against the Sincitial Respiratory Virus (VRS), the leading cause of acute bronchiolitis in babies and the disease responsible for a large part of hospital admissions in children under 2 years of age in Euskadi.
Decision Forum says yes to preventive treatment against RS virus for newborns and young children at high risk. On Monday, the forum addressed both klesrovimab (Enflonsia) and nirsevimab (Beyfortus).
On Monday, the Xunta launched a campaign to immunize children against the syncytial respiratory virus, which protects infants from one of the main causes of respiratory infection and hospitalization in the first few months of life.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
